Abstract:Cigarette smoke, a toxic collection of more than 4000 chemicals generated from combustion of tobacco plant leaves, is known to cause several respiratory ailments, including chronic bronchitis, emphysema and lung cancer, and is associated with an increase in respiratory infections. In addition, cigarette smoking is considered a principal aetiological factor responsible for the development of certain diffuse interstitial and bronchiolar lung diseases, namely respiratory bronchiolitis-interstitial lung disease (RB-ILD), desquamative interstitial pneumonia (DIP) and adult pulmonary Langerhans’ cell histiocytosis (PLCH). Although not exclusively seen in cigarette smokers, substantial clinical and epidemiological data support a central role for smoking as the primary causative agent of most RB-ILD, DIP and PLCH. Additional evidence in support of cigarette smoke as a primary aetiological agent in RB-ILD, DIP and PLCH is the observation that smoking cessation may lead to disease improvement, while recurrence of these disorders has been observed to occur in the transplanted lung upon re-exposure to tobacco smoke. Furthermore, histopathological changes of respiratory bronchiolitis, DIP and PLCH (with or without co-existent emphysema) may be found on lung biopsy in the same individual, implicating smoking as a common inciting agent of these diverse lesions. Recent studies also suggest a role for cigarette smoking as a potential co-factor in the development of acute eosinophilic pneumonia, usual interstitial pneumonia and rheumatoid arthritis-associated interstitial lung disease. In the current review, we propose a novel classification that takes into account the complex relationship between cigarette smoking and diffuse lung diseases. Investigation on the role of smoking as a potential causative factor or modifier of these diverse diffuse lung diseases is important, as smoking cessation utilizing state-of-the-art tobacco cessation efforts should be a central part of therapy, while pharmacotherapy with corticosteroids or other immune modifying agents should be reserved for selected patients.

Effects of Smoking on Respiratory System

Effect of Nicotine on Pulmonary Pathogenic Bacteria

Cigarette Smoking and Diffuse Lung Disease

Impacts Of Cigarette Smoking On Immune Responsiveness: Up And Down Or Upside Down?

Impact of smoking on pharmacotherapy of chronic obstructive pulmonary disease

Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease

Cigarette Smoke Exposure Exacerbates Lung Inflammation and Compromises Immunity to Bacterial Infection

Cigarette smoke inhibits human bronchial epithelial cell repair processes.

[The role of smoking in changing essential parameters in body homeostasis]

The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis

Are healthy smokers really healthy?

Effects of Nicotine on Oral Microorganisms, Human Tissues, and the Interactions between Them

Effects of Smoking on the Pathogenesis of Chronic Obstructive Pulmonary Disease

The peripheral vascular consequences of smoking

[Smoking and the skin]

Advancements in Cardiovascular Disease Research Affected by Smoking

Smoking-induced microbial dysbiosis in health and disease

Research progress on the impact of smoking on innate immunity

Cigarette Smoke Induced Lung Barrier Dysfunction, EMT, and Tissue Remodeling: A Possible Link between COPD and Lung Cancer

Oxidative stress and inflammation: elucidating mechanisms of smoking-attributable pathology for therapeutic targeting